Skip to content

Drug interactions

Etoposide + Voxelotor

Severity: Moderate

Etoposide and Voxelotor: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Voxelotor inhibits CYP3A4 in vitro and increases exposure to sensitive CYP3A4 substrates. Etoposide is partly CYP3A4-metabolised, so levels may rise modestly, but etoposide is not a sensitive substrate and the clinical effect is uncertain.

What this interaction means in plain words

Etoposide and Voxelotor can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Etoposide belongs to Oncology; Voxelotor belongs to Miscellaneous.

Evidence level: Low

Why it happens

Voxelotor inhibits CYP3A4, which may reduce the metabolism of etoposide.

What to do

Monitor blood counts and signs of etoposide toxicity during co-administration. Reduce the etoposide dose if marked myelosuppression occurs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Etoposide and Voxelotor, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Etoposide with Voxelotor?

MediHelp rates the interaction as moderate. Etoposide and Voxelotor can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Voxelotor inhibits CYP3A4 in vitro and increases exposure to sensitive CYP3A4 substrates. Etoposide is partly CYP3A4-metabolised, so levels may rise modestly, but etoposide is not a sensitive substrate and the clinical effect is uncertain.

How serious is the interaction between Etoposide and Voxelotor?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts and signs of etoposide toxicity during co-administration. Reduce the etoposide dose if marked myelosuppression occurs.

What other medicines interact with Etoposide?

MediHelp also lists interactions of Etoposide with, for example, Adenovirus types 4 and 7 live, Pentostatin, Cyclosporin. The full list is on the Etoposide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in